Burning Rock Biotech (Burning Rock Biotech) Total Stockholders Equity : $118.25 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Total Stockholders Equity?

Burning Rock Biotech's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $118.25 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Burning Rock Biotech's Book Value per Share for the quarter that ended in Sep. 2023 was $1.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Burning Rock Biotech's Debt-to-Equity for the quarter that ended in Sep. 2023 was 0.02.

Burning Rock Biotech Total Stockholders Equity Historical Data

The historical data trend for Burning Rock Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Total Stockholders Equity Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-87.67

-127.11

370.22

289.72

166.15

Burning Rock Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Stockholders Equity	Get a 7-Day Free Trial															185.05	166.15	151.73	135.11	118.25

Burning Rock Biotech (NAS:BNR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Burning Rock Biotech's Book Value per Share for the quarter that ended in Sep. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(118.249	-	0)	/	102.326
	=	1.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Burning Rock Biotech's Debt-to-Equity for the quarter that ended in Sep. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.916	+	0.7)	/	118.249
	=	0.02

Burning Rock Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.